(GBDC) Golub Capital BDC - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US38173M1027

Senior Debt, Unitranche, Mezzanine, Equity

GBDC EPS (Earnings per Share)

EPS (Earnings per Share) of GBDC over the last years for every Quarter: "2020-09": 0.28, "2020-12": 0.56, "2021-03": 0.55, "2021-06": 0.49, "2021-09": 0.42, "2021-12": 0.37, "2022-03": 0.39, "2022-06": 0.09, "2022-09": 0.05, "2022-12": 0.15, "2023-03": 0.34, "2023-06": 0.43, "2023-09": 0.6, "2023-12": 0.45, "2024-03": 0.55, "2024-06": 0.05, "2024-09": 0.45, "2024-12": 0.37, "2025-03": 0.37, "2025-06": 0.38, "2025-09": 0,

GBDC Revenue

Revenue of GBDC over the last years for every Quarter: 2020-09: 72.012, 2020-12: 74.046, 2021-03: 76.201, 2021-06: 75.769, 2021-09: 81.109, 2021-12: 86.567, 2022-03: 85.961, 2022-06: 94.487, 2022-09: 119.648, 2022-12: 135.381, 2023-03: 145.647, 2023-06: 153.75, 2023-09: 164.118, 2023-12: 121.793, 2024-03: 136.617, 2024-06: 58.849, 2024-09: 158.47, 2024-12: 195.781, 2025-03: 154.107, 2025-06: 218.72, 2025-09: null,

Description: GBDC Golub Capital BDC November 07, 2025

Golub Capital BDC, Inc. (NASDAQ: GBDC) is an externally-managed, closed-end business development company that focuses on debt and minority-equity investments in U.S. middle-market firms, many of which are backed by private-equity sponsors.

The firm’s portfolio spans diversified consumer services, automotive, healthcare technology, insurance, health-care equipment and supplies, hospitality, IT services, and specialty retail, with a typical investment range of first-lien senior debt, unitranche, second-lien, mezzanine loans, and accompanying warrants.

As of the most recent filing, GBDC reported a net asset value (NAV) of roughly $2.6 billion, a distribution yield near 8 %, and a portfolio composition of about 70 % senior secured debt, 20 % mezzanine/second-lien exposure, and 10 % equity-linked positions; the average loan size is approximately $30 million, supporting companies with median EBITDA of roughly $100 million.

Key macro drivers include the prevailing interest-rate environment-higher rates can boost GBDC’s yield on new debt but also widen credit spreads, potentially increasing default risk-and the continued growth of private-equity capital, which fuels a steady pipeline of sponsor-backed deal flow.

Sector-specific tailwinds, such as the aging U.S. population and rising adoption of digital health solutions, are bolstering demand for healthcare-technology and equipment financing, which together represent a sizable slice of GBDC’s exposure.

For a deeper quantitative breakdown of GBDC’s risk-adjusted returns, the ValueRay platform offers a granular view of its portfolio metrics.

GBDC Stock Overview

Market Cap in USD 3,700m
Sub-Industry Asset Management & Custody Banks
IPO / Inception 2010-04-15

GBDC Stock Ratings

Growth Rating 47.0%
Fundamental 44.5%
Dividend Rating 84.4%
Return 12m vs S&P 500 -13.3%
Analyst Rating 4.0 of 5

GBDC Dividends

Dividend Yield 12m 11.69%
Yield on Cost 5y 19.21%
Annual Growth 5y 11.68%
Payout Consistency 96.1%
Payout Ratio 139.3%

GBDC Growth Ratios

Growth Correlation 3m -65.9%
Growth Correlation 12m 12.9%
Growth Correlation 5y 84.9%
CAGR 5y 13.00%
CAGR/Max DD 3y (Calmar Ratio) 0.76
CAGR/Mean DD 3y (Pain Ratio) 3.03
Sharpe Ratio 12m 0.62
Alpha -8.87
Beta 0.490
Volatility 14.87%
Current Volume 1289.6k
Average Volume 20d 1812k
Stop Loss 13.3 (-3.4%)
Signal 0.04

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income (375.6m TTM) > 0 and > 6% of Revenue (6% = 43.6m TTM)
FCFTA -0.06 (>2.0%) and ΔFCFTA -13.45pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 25.53% (prev 30.13%; Δ -4.60pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA -0.06 (>3.0%) and CFO -579.7m <= Net Income 375.6m (YES >=105%, WARN >=100%)
Net Debt (-170.9m) to EBITDA (421.8m) ratio: -0.41 <= 3.0 (WARN <= 3.5)
Current Ratio 4.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (266.8m) change vs 12m ago 33.44% (target <= -2.0% for YES)
Gross Margin 65.28% (prev 62.84%; Δ 2.44pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 8.21% (prev 5.68%; Δ 2.53pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.51 (EBITDA TTM 421.8m / Interest Expense TTM 279.4m) >= 6 (WARN >= 3)

Altman Z'' 0.34

(A) 0.02 = (Total Current Assets 241.7m - Total Current Liabilities 56.0m) / Total Assets 9.24b
(B) -0.02 = Retained Earnings (Balance) -207.9m / Total Assets 9.24b
(C) 0.05 = EBIT TTM 421.8m / Avg Total Assets 8.86b
(D) -0.04 = Book Value of Equity -207.6m / Total Liabilities 5.24b
Total Rating: 0.34 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 44.53

1. Piotroski 4.0pt = -1.0
2. FCF Yield -7.13% = -3.57
3. FCF Margin -79.74% = -7.50
4. Debt/Equity 1.15 = 1.87
5. Debt/Ebitda -0.41 = 2.50
6. ROIC - WACC (= 0.42)% = 0.53
7. RoE 9.35% = 0.78
8. Rev. Trend 27.32% = 2.05
9. EPS Trend -22.68% = -1.13

What is the price of GBDC shares?

As of November 08, 2025, the stock is trading at USD 13.77 with a total of 1,289,609 shares traded.
Over the past week, the price has changed by -0.86%, over one month by +0.58%, over three months by -4.31% and over the past year by -0.45%.

Is Golub Capital BDC a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Golub Capital BDC (NASDAQ:GBDC) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 44.53 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GBDC is around 15.09 USD . This means that GBDC is currently overvalued and has a potential downside of 9.59%.

Is GBDC a buy, sell or hold?

Golub Capital BDC has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy GBDC.
  • Strong Buy: 2
  • Buy: 1
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the GBDC price?

Issuer Target Up/Down from current
Wallstreet Target Price 15.3 10.7%
Analysts Target Price 15.3 10.7%
ValueRay Target Price 16.2 17.6%

GBDC Fundamental Data Overview October 31, 2025

Market Cap USD = 3.70b (3.70b USD * 1.0 USD.USD)
P/E Trailing = 9.7817
P/E Forward = 9.2851
P/S = 4.2172
P/B = 0.9161
P/EG = 1.51
Beta = 0.49
Revenue TTM = 727.1m USD
EBIT TTM = 421.8m USD
EBITDA TTM = 421.8m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 4.60b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -170.9m USD (from netDebt column, last quarter)
Enterprise Value = 8.13b USD (3.70b + Debt 4.60b - CCE 170.9m)
Interest Coverage Ratio = 1.51 (Ebit TTM 421.8m / Interest Expense TTM 279.4m)
FCF Yield = -7.13% (FCF TTM -579.7m / Enterprise Value 8.13b)
FCF Margin = -79.74% (FCF TTM -579.7m / Revenue TTM 727.1m)
Net Margin = 51.65% (Net Income TTM 375.6m / Revenue TTM 727.1m)
Gross Margin = 65.28% ((Revenue TTM 727.1m - Cost of Revenue TTM 252.4m) / Revenue TTM)
Gross Margin QoQ = 79.99% (prev 56.24%)
Tobins Q-Ratio = 0.88 (Enterprise Value 8.13b / Total Assets 9.24b)
Interest Expense / Debt = 1.54% (Interest Expense 70.7m / Debt 4.60b)
Taxrate = -0.23% (negative due to tax credits) (-211.0k / 89.8m)
NOPAT = 422.8m (EBIT 421.8m * (1 - -0.23%)) [negative tax rate / tax credits]
Current Ratio = 4.32 (Total Current Assets 241.7m / Total Current Liabilities 56.0m)
Debt / Equity = 1.15 (Debt 4.60b / totalStockholderEquity, last quarter 4.00b)
Debt / EBITDA = -0.41 (Net Debt -170.9m / EBITDA 421.8m)
Debt / FCF = 0.29 (negative FCF - burning cash) (Net Debt -170.9m / FCF TTM -579.7m)
Total Stockholder Equity = 4.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.07% (Net Income 375.6m / Total Assets 9.24b)
RoE = 9.35% (Net Income TTM 375.6m / Total Stockholder Equity 4.02b)
RoCE = 4.59% (EBIT 421.8m / Capital Employed (Total Assets 9.24b - Current Liab 56.0m))
RoIC = 4.76% (NOPAT 422.8m / Invested Capital 8.87b)
WACC = 4.34% (E(3.70b)/V(8.30b) * Re(7.82%) + D(4.60b)/V(8.30b) * Rd(1.54%) * (1-Tc(-0.00)))
Discount Rate = 7.82% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 25.42%
Fair Price DCF = unknown (Cash Flow -579.7m)
EPS Correlation: -22.68 | EPS CAGR: -44.30% | SUE: -2.25 | # QB: 0
Revenue Correlation: 27.32 | Revenue CAGR: 24.53% | SUE: 0.03 | # QB: 0

Additional Sources for GBDC Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle